Published in Health Risk Factor Week, December 5th, 2006
"In Korea, most thyroid cancer is the classic papillary type and the BRAF(V600E) mutation is highly prevalent. To evaluate the role of pre-operative detection of BRAF(V600E) mutation in the FNAB specimens of thyroid nodules...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.